Antioxidants protect against dopamine-induced metallothionein-III (GIF) mRNA expression in mouse glial cell line (VR-2g)

Chiharu Sogawa, Ikuko Miyazaki, Norio Sogawa, Masato Asanuma, Norio Ogawa, Hiroaki Furuta

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Metallothionein (MT)-III, originally discovered as a growth inhibitory factor (GIF), is a brain specific isomer of MTs and is markedly reduced in the brain of patients with Alzheimer's disease (AD) or other neurodegenerative diseases. We analyzed the level and regulation of mRNA expression of MT-III in immortalized fetal mouse brain glial cells (VR-2g) by reverse transcriptase-polymerase chain reaction (RT-PCR). We have recently reported that dopamine (DA) increases the expression of MT-III mRNA in vitro. In this study, we investigated the mechanism of such increase by examining the effects of DA agonists (SKF38393 or bromocriptine) and DA antagonists (SCH23390 or sulpiride) on the expression of MT-III mRNA. MT-III mRNA did not change by either agonist and DA-increased MT-III mRNA was not inhibited by either antagonist. These results suggested that the induction of MT-III mRNA by DA was not mediated by stimulation of DA receptors. On the other hand, DA-induced MT-III mRNA expression was strongly inhibited by the addition of antioxidants (glutathione, vitamin E or ascorbic acid), indicating that DA-enhanced MT-III mRNA was mediated by reactive oxygen species. Our results suggest that oxidative stress may be one of the principle factors that modulate MT-III mRNA expression. Copyright (C) 2000 Elsevier Science B.V.

Original languageEnglish
Pages (from-to)310-316
Number of pages7
JournalBrain Research
Volume853
Issue number2
DOIs
Publication statusPublished - Jan 24 2000

Fingerprint

Neuroglia
Dopamine
Antioxidants
Cell Line
Messenger RNA
Dopamine Agonists
Brain
growth inhibitory factor
2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine
Sulpiride
Bromocriptine
Dopamine Antagonists
Dopamine Receptors
Reverse Transcriptase Polymerase Chain Reaction
Vitamin E
Neurodegenerative Diseases
Ascorbic Acid
Glutathione
Reactive Oxygen Species
Alzheimer Disease

Keywords

  • Antioxidant
  • Dopamine
  • Dopamine receptor
  • Glial cell
  • Growth inhibitory factor (GIF)
  • Metallothionein-III

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Antioxidants protect against dopamine-induced metallothionein-III (GIF) mRNA expression in mouse glial cell line (VR-2g). / Sogawa, Chiharu; Miyazaki, Ikuko; Sogawa, Norio; Asanuma, Masato; Ogawa, Norio; Furuta, Hiroaki.

In: Brain Research, Vol. 853, No. 2, 24.01.2000, p. 310-316.

Research output: Contribution to journalArticle

@article{20174b75cd8a421ba23c53e83bfbf2bd,
title = "Antioxidants protect against dopamine-induced metallothionein-III (GIF) mRNA expression in mouse glial cell line (VR-2g)",
abstract = "Metallothionein (MT)-III, originally discovered as a growth inhibitory factor (GIF), is a brain specific isomer of MTs and is markedly reduced in the brain of patients with Alzheimer's disease (AD) or other neurodegenerative diseases. We analyzed the level and regulation of mRNA expression of MT-III in immortalized fetal mouse brain glial cells (VR-2g) by reverse transcriptase-polymerase chain reaction (RT-PCR). We have recently reported that dopamine (DA) increases the expression of MT-III mRNA in vitro. In this study, we investigated the mechanism of such increase by examining the effects of DA agonists (SKF38393 or bromocriptine) and DA antagonists (SCH23390 or sulpiride) on the expression of MT-III mRNA. MT-III mRNA did not change by either agonist and DA-increased MT-III mRNA was not inhibited by either antagonist. These results suggested that the induction of MT-III mRNA by DA was not mediated by stimulation of DA receptors. On the other hand, DA-induced MT-III mRNA expression was strongly inhibited by the addition of antioxidants (glutathione, vitamin E or ascorbic acid), indicating that DA-enhanced MT-III mRNA was mediated by reactive oxygen species. Our results suggest that oxidative stress may be one of the principle factors that modulate MT-III mRNA expression. Copyright (C) 2000 Elsevier Science B.V.",
keywords = "Antioxidant, Dopamine, Dopamine receptor, Glial cell, Growth inhibitory factor (GIF), Metallothionein-III",
author = "Chiharu Sogawa and Ikuko Miyazaki and Norio Sogawa and Masato Asanuma and Norio Ogawa and Hiroaki Furuta",
year = "2000",
month = "1",
day = "24",
doi = "10.1016/S0006-8993(99)02284-2",
language = "English",
volume = "853",
pages = "310--316",
journal = "Brain Research",
issn = "0006-8993",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - Antioxidants protect against dopamine-induced metallothionein-III (GIF) mRNA expression in mouse glial cell line (VR-2g)

AU - Sogawa, Chiharu

AU - Miyazaki, Ikuko

AU - Sogawa, Norio

AU - Asanuma, Masato

AU - Ogawa, Norio

AU - Furuta, Hiroaki

PY - 2000/1/24

Y1 - 2000/1/24

N2 - Metallothionein (MT)-III, originally discovered as a growth inhibitory factor (GIF), is a brain specific isomer of MTs and is markedly reduced in the brain of patients with Alzheimer's disease (AD) or other neurodegenerative diseases. We analyzed the level and regulation of mRNA expression of MT-III in immortalized fetal mouse brain glial cells (VR-2g) by reverse transcriptase-polymerase chain reaction (RT-PCR). We have recently reported that dopamine (DA) increases the expression of MT-III mRNA in vitro. In this study, we investigated the mechanism of such increase by examining the effects of DA agonists (SKF38393 or bromocriptine) and DA antagonists (SCH23390 or sulpiride) on the expression of MT-III mRNA. MT-III mRNA did not change by either agonist and DA-increased MT-III mRNA was not inhibited by either antagonist. These results suggested that the induction of MT-III mRNA by DA was not mediated by stimulation of DA receptors. On the other hand, DA-induced MT-III mRNA expression was strongly inhibited by the addition of antioxidants (glutathione, vitamin E or ascorbic acid), indicating that DA-enhanced MT-III mRNA was mediated by reactive oxygen species. Our results suggest that oxidative stress may be one of the principle factors that modulate MT-III mRNA expression. Copyright (C) 2000 Elsevier Science B.V.

AB - Metallothionein (MT)-III, originally discovered as a growth inhibitory factor (GIF), is a brain specific isomer of MTs and is markedly reduced in the brain of patients with Alzheimer's disease (AD) or other neurodegenerative diseases. We analyzed the level and regulation of mRNA expression of MT-III in immortalized fetal mouse brain glial cells (VR-2g) by reverse transcriptase-polymerase chain reaction (RT-PCR). We have recently reported that dopamine (DA) increases the expression of MT-III mRNA in vitro. In this study, we investigated the mechanism of such increase by examining the effects of DA agonists (SKF38393 or bromocriptine) and DA antagonists (SCH23390 or sulpiride) on the expression of MT-III mRNA. MT-III mRNA did not change by either agonist and DA-increased MT-III mRNA was not inhibited by either antagonist. These results suggested that the induction of MT-III mRNA by DA was not mediated by stimulation of DA receptors. On the other hand, DA-induced MT-III mRNA expression was strongly inhibited by the addition of antioxidants (glutathione, vitamin E or ascorbic acid), indicating that DA-enhanced MT-III mRNA was mediated by reactive oxygen species. Our results suggest that oxidative stress may be one of the principle factors that modulate MT-III mRNA expression. Copyright (C) 2000 Elsevier Science B.V.

KW - Antioxidant

KW - Dopamine

KW - Dopamine receptor

KW - Glial cell

KW - Growth inhibitory factor (GIF)

KW - Metallothionein-III

UR - http://www.scopus.com/inward/record.url?scp=0033987764&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033987764&partnerID=8YFLogxK

U2 - 10.1016/S0006-8993(99)02284-2

DO - 10.1016/S0006-8993(99)02284-2

M3 - Article

C2 - 10640628

AN - SCOPUS:0033987764

VL - 853

SP - 310

EP - 316

JO - Brain Research

JF - Brain Research

SN - 0006-8993

IS - 2

ER -